Consistent Production of Genetically Stable Mammalian Cell Lines - The author describes expression technology that produces cell lines with high genetic stability. This article is part of a special se

ADVERTISEMENT

Consistent Production of Genetically Stable Mammalian Cell Lines
The author describes expression technology that produces cell lines with high genetic stability. This article is part of a special section on expression systems.


BioPharm International
Volume 25, Issue 5, pp. 56-59

GPEX AND GENETIC STABILITY


Figure 5
Because of the genetic stability of GPEx generated cell lines, stability studies do not need to be performed as part of the cell line selection process. Cell lines selected to master cell bank are chosen strictly based on protein expression and protein quality. Once the master cell bank is produced, confirmation of cell line genetic stability is performed on the bank. Results for 17 GPEx cell banks each producing a different protein are shown in Figure 4. The cell bank for each cell line was designated as generation 0 for the purpose of the study. Cells were continuously cultured by serial passage from generation 0 to approximately generation 40 or 60 depending on the study protocol. At the end of the experiment, samples of cells from the generation 0 cell bank and from the generation 40 or 60 culture were used for DNA and RNA isolation. Real-time PCR analysis of the DNA showed no significant difference between the number of transgenes at generation 0 and generation 40 or 60 for any of the 17 banks. To examine the stability of mRNA expression, cell banks producing seven different antibodies were tested at generation 0 and 60. Heavy and light chain mRNA levels were estimated individually at the two time points for each of the cell lines. No significant differences in heavy chain or light chain mRNA levels over the extended culture were observed (see Figure 5).

CONCLUSIONS

The GPEx method of gene insertion consistently produces genetically stable cell lines. The fact the gene inserts are single copy make the method inherently more stable than any technique that results in more than one copy of the transgene inserted at a single chromosomal location. This innate genetic stability of the cell lines allows biopharmaceutical development timelines to be shortened 3–5 months by removing cell line stability screening from the critical path.

GREGORY T. BLECK, PHD, Research and Development Platform Lead- Biologics, Catalent Pharma Solutions, Middleton WI,
.

REFERENCES

1. B.J. Pomerantz et al., Mol. Cell. Biol. 3 (9), 1680–1685 (1983).

2. K. Strutzenberger et al., J. Biotech 69, 215–226 (1999).

3. N.S. Kim et al., Biotech. Bioeng. 60 (6), 679–688 (1998).

4. L.M. Barnes et al., Biotech. Bioeng. 85 (2), 115–121 (2004).

5. M.D. Andrake and A.M. Skalka, J. Biol. Chem. 271 (33), 19633–19636 (1996).

6 R. Schlegel et al., Cell 32, 639–646 (1983).

7. J.C. Burns et al., Proc. Natl. Acad. Sci. USA 90, 8033–8037 (1993).

8. J.K. Yee, T. Friedmann, and T.C. Burns, Methods Cell Biol. 43, 99–112 (1994).

9. X. Wu et al., Sci. 300, 1749–1751 (2003).

10. R.S. Mitchell et al., PLOS Biology 2 (8), 1127–1137 (2004).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here